CTCF and cancer: In addition, Katinen et al. recently demonstrated CTCF/cohesin binding sites are frequently mutated in cancer, providing another mechanism for disrupting CTCF genome regulation by inhibiting CTCF recognition at specific DNA binding sites [45].